Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

NCT00467987 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

47

Enrollment

OTHER

Sponsor class

Stopped Company no longer making same drug doses.

Conditions

Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

Interventions

DRUG: androgel
DRUG: placebo

Sponsor

University at Buffalo

Collaborators

[object Object]